ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity: Molecular Therapy
Functional exhaustion of CD4+ T cells induced by co‐stimulatory signals from myeloid leukaemia cells - Ozkazanc - 2016 - Immunology - Wiley Online Library
CD4+ICOS+Foxp3+: a sub-population of regulatory T cells contribute to malaria pathogenesis | Malaria Journal | Full Text
ICOS deficiency hampers the homeostasis, development and function of NK cells | PLOS ONE
Frontiers | ICOS Co-Stimulation: Friend or Foe?
ICOS/CD278 Extracellular Domain (human, recombinant) (Activation-inducible Lymphocyte Immunomediatory Molecule, AILIM, CVID1, Inducible T Cell Costimulator) | Cayman Chemical
Raji-hICOS cells | ADCC target cells | InvivoGen
Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies | Nature Communications
A Guide to Natural Killer T Cell Markers | Biocompare: The Buyer's Guide for Life Scientists
CD278 (ICOS) Monoclonal Antibody (ISA-3), Alexa Fluor™ 700 (56-9948-42)
Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS) - ScienceDirect
ICOS Gene - GeneCards | ICOS Protein | ICOS Antibody
Blockade of ICOS-ICOSL affects the expressions of CD4hi Treg markers.
ICOS and ICOSL Immune Checkpoints for Immuno-oncology Research from Adipogen Life Sciences
ICOS costimulation is indispensable for the differentiation of T follicular regulatory cells | Life Science Alliance
Cells | Free Full-Text | The Regulatory-T-Cell Memory Phenotype: What We Know
ICOS Gene - GeneCards | ICOS Protein | ICOS Antibody
Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies | Nature Communications
Frontiers | ICOS+ Tregs: A Functional Subset of Tregs in Immune Diseases
Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy | BMC Cancer | Full Text
Schematic representation of the dual role of ICOS/ICOSL pathway in... | Download Scientific Diagram
Frontiers | PD-1 and ICOS counter-regulate tissue resident regulatory T cell development and IL-10 production during flu
JCI - PD-1 and ICOS coexpression identifies tumor-reactive CD4+ T cells in human solid tumors
Frontiers | ICOS Co-Stimulation: Friend or Foe?
